Mark A. Watson, MD, PhD

Associate Professor of Pathology and Immunology

Washington University in St. Louis (WU)

Application of whole genomic technologies (e.g. DNA microarrays) and biomedical informatics approaches to the molecular characterization of breast cancer and other malignancies. Development and validation of genome-based biomarkers for the prognosis and targeted therapeutic management of cancer.